Updated:
Aviron
Aviron is a biopharmaceutical company based in Mountain View, California. Its product portfolio includes FluMist, a live virus vaccine for influenza...
Aviron
Aviron is a biopharmaceutical company based in Mountain View, California. Its product portfolio includes FluMist, a live virus vaccine for influenza prevention, as well as vaccines for parainfluenza virus type 3, Epstein-Barr virus, and cytomegalovirus.
General information
Firm type
Generalist
Location
Region
Latin America
Country
Chile
City
Santiago
Corporate office
Santiago, Chile
Frequently asked questions
What investment stages and asset classes does Aviron target?
Aviron's generalist mandate covers private equity, real assets, and public-market securities. The firm can allocate across stages — from early-stage venture to mature buyouts — depending on opportunity. Without specific portfolio disclosures, the exact stage concentration is not publicly known.
Where does Aviron's capital come from?
Unlike Chilean single-family offices tied to a specific wealth origin, Aviron is an independent asset manager. Its funding comes from external clients whose identities are not publicly disclosed. The firm does not appear to be the captive investment arm of a family or corporate group.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: